ArticleCancer research2015

Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma.

Elizabeth A Kuczynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.